Open access · CC-BY via OpenAlex

Application of Induced Pluripotent Stem Cell Technology to the Study of Hematological Diseases

Mailin Li, Pasquale Cascino, Simone Ummarino, Annalisa Di Ruscio

Cells · 2017 · ▲ 15 citations

Stem-cell exhaustion Partial reprogramming (OSK) Human Review

Abstract

The burst of reprogramming technology in recent years has revolutionized the field of stem cell biology, offering new opportunities for personalized, regenerative therapies. The direct reprogramming of somatic cells to induced pluripotent stem cells (iPSCs) has provided an invaluable tool to study and model a wide range of human diseases. Here, we review the transforming potential of such a strategy in research and in therapies applicable to the hematology field.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: OpenAlex
DOI: 10.3390/cells6010007
Canonical: link ↗
Fetched: 2026-10-10 MST

Cite this

APA

Li, M., Cascino, P., Ummarino, S., & Ruscio, A.D. (2017). Application of Induced Pluripotent Stem Cell Technology to the Study of Hematological Diseases. <em>Cells</em>. https://doi.org/10.3390/cells6010007

Vancouver

Li M, Cascino P, Ummarino S, Ruscio AD. Application of Induced Pluripotent Stem Cell Technology to the Study of Hematological Diseases. Cells. 2017. doi:10.3390/cells6010007.

BibTeX

@article{mailin2017Applic, title = {Application of Induced Pluripotent Stem Cell Technology to the Study of Hematological Diseases}, author = {Mailin Li and Pasquale Cascino and Simone Ummarino and Annalisa Di Ruscio}, journal = {Cells}, year = {2017}, doi = {10.3390/cells6010007}, }